Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human HNRNPUL2 Antibody | Login | Human HNRNPUL2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human LDLRAD2 Antibody | Login | Human LDLRAD2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human ACSS1 Antibody | Login | Human ACSS1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human DDX3Y Antibody | Login | Human DDX3Y Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human CMC1 Antibody | Login | Human CMC1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human CHST2 Antibody | Login | Human CHST2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Human CEP135 Antibody | Login | Human CEP135 Antibody | ||||||||||||||||
|
||||||||||||||||||
| SERTAD1 (SERTA domain containing 1) | Login | SERTAD1 (SERTA domain containing 1) | ||||||||||||||||
|
||||||||||||||||||
| Desmin | Login | Desmin | ||||||||||||||||
|
||||||||||||||||||
| p37 [1320] | Login | p37 [1320] | ||||||||||||||||
|
||||||||||||||||||
| CRSP6 (cofactor required for Sp1 transcriptional activation. subunit 6. 77kDa) | Login | CRSP6 (cofactor required for Sp1 transcriptional activation. subunit 6. 77kDa) | ||||||||||||||||
|
||||||||||||||||||
| CD4 [Q4120] | Login | CD4 [Q4120] | ||||||||||||||||
|
||||||||||||||||||
| SIRT1 (sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae)) | Login | SIRT1 (sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae)) | ||||||||||||||||
|
||||||||||||||||||
| BRCA1 [8F7] | Login | BRCA1 [8F7] | ||||||||||||||||
|
||||||||||||||||||
| SREBF1 | Login | SREBF1 | ||||||||||||||||
|
||||||||||||||||||
| IgG (Fc) | Login | IgG (Fc) | ||||||||||||||||
|
||||||||||||||||||
| EAP30 | Login | EAP30 | ||||||||||||||||
|
||||||||||||||||||
| Desmin (ready-to-use) | Login | Desmin (ready-to-use) | ||||||||||||||||
|
||||||||||||||||||
| p73 delta N [38C674] | Login | p73 delta N [38C674] | ||||||||||||||||
|
||||||||||||||||||
| Goat anti Mouse IgG (Fc) | Login | Goat anti Mouse IgG (Fc) | ||||||||||||||||
|
||||||||||||||||||
| Transportin 1 [D45] | Login | Transportin 1 [D45] | ||||||||||||||||
|
||||||||||||||||||
| WHSC1 (Wolf-Hirschhorn syndrome candidate 1) | Login | WHSC1 (Wolf-Hirschhorn syndrome candidate 1) | ||||||||||||||||
|
||||||||||||||||||
| RB1 (retinoblastoma 1 (including osteosarcoma)) | Login | RB1 (retinoblastoma 1 (including osteosarcoma)) | ||||||||||||||||
|
||||||||||||||||||
| KIN (KIN. antigenic determinant of recA protein homolog (mouse)) | Login | KIN (KIN. antigenic determinant of recA protein homolog (mouse)) | ||||||||||||||||
|
||||||||||||||||||
| IgG | Login | IgG | ||||||||||||||||
|
||||||||||||||||||


